When it comes to NVDA… “acceleration cycles” are the key

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!

JoAnn Reed Biography and Net Worth

Director of Waters

Ms. JoAnn A. Reed serves as an Independent Director of Waters Corporation, since May 2006. Ms. Reed has been a health care services consultant since 2010. From April 2008 to April 2009, she was an advisor to the Chief Executive Officer of Medco Health Solutions, Inc. From 2002 to March 2008, Ms. Reed served as Senior Vice President, Finance and Chief Financial Officer of Medco Health Solutions, Inc. From 1992 to 2002, she served as Senior Vice President, Finance of Medco Health Solutions, Inc. She joined Medco Containment Services, Inc. in 1988. Her prior experience includes employment with CBS, Inc., Aetna/American Re-insurance Co., Standard and Poor’s Financial Services LLC, and Unisys/Timeplex. Ms. Reed’s extensive experience as a senior financial executive provides the Waters Board with significant accounting, finance and health care industry expertise.

What is JoAnn A. Reed's net worth?: The estimated net worth of JoAnn A. Reed is at least $19.98 million as of October 28th, 2022. Ms. Reed owns 54,554 shares of Waters stock worth more than $19,983,676 as of November 21st. This net worth estimate does not reflect any other assets that Ms. Reed may own. Learn More about JoAnn A. Reed's net worth.
How do I contact JoAnn A. Reed?: The corporate mailing address for Ms. Reed and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on JoAnn A. Reed's contact information.
Has JoAnn A. Reed been buying or selling shares of Waters?: JoAnn A. Reed has not been actively trading shares of Waters over the course of the past ninety days. Most recently, Joann A. Reed sold 1,600 shares of the business's stock in a transaction on Friday, March 5th. The shares were sold at an average price of $263.31, for a transaction totalling $421,296.00. Learn More on JoAnn A. Reed's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $332,900.00. During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,624,330.00. The most recent insider tranaction occured on May, 28th when Director Richard H Fearon bought 1,000 shares worth more than $332,900.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 5/28/2024.

JoAnn A. Reed Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2021	Sell	1,600	$263.31	$421,296.00
2/9/2021	Sell	4,759	$282.39	$1,343,894.01	36,683
1/2/2020	Sell	5,194	$234.67	$1,218,875.98	25,323
5/22/2018	Sell	2,090	$195.77	$409,159.30	17,932
1/2/2018	Sell	1,386	$194.07	$268,981.02
1/4/2016	Sell	5,003	$132.18	$661,296.54	16,461

JoAnn A. Reed Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $367.58

$357.41

$368.01

50 Day Range

MA: $352.17

$322.08

$387.34

2 Week Range

Now: $367.58

$273.60

$393.38

Volume

275,268 shs

Average Volume

435,665 shs

Market Capitalization

$21.83 billion

P/E Ratio

35.07

Dividend Yield

N/A

Beta

0.97